Correction to: short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.
作者信息
Weinstein D A, Jackson R J, Brennan E A, Williams M, Davison J E, de Boer F, Derks Tgj, Ellerton C, Faragher B, Gribben J, Labrune P, McKittrick K M, Murphy E, Ross K M, Steuerwald U, Voillot C, Woodward Ajm, Mundy H R
机构信息
Glycogen Storage Disease Program, Connecticut Children's Medical Center, Hartford, USA.
School of Medicine, Department of Pediatrics, University of Connecticut, Farmington, CT, USA.
出版信息
Orphanet J Rare Dis. 2024 Aug 30;19(1):317. doi: 10.1186/s13023-024-03305-8.
Abstract
摘要
相似文献
1
Correction to: short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.
Orphanet J Rare Dis. 2024 Aug 30;19(1):317. doi: 10.1186/s13023-024-03305-8.
2
Short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.
Orphanet J Rare Dis. 2024 Jul 9;19(1):258. doi: 10.1186/s13023-024-03274-y.
3
Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I.
JIMD Rep. 2016;26:85-90. doi: 10.1007/8904_2015_488. Epub 2015 Aug 25.
4
A novel starch for the treatment of glycogen storage diseases.
J Inherit Metab Dis. 2007 Jun;30(3):350-7. doi: 10.1007/s10545-007-0479-0. Epub 2007 May 19.
5
Efficacy of cornstarch therapy in type III glycogen-storage disease.
Am J Clin Nutr. 1990 Oct;52(4):671-4. doi: 10.1093/ajcn/52.4.671.
6
Potential use of other starch sources in the treatment of glycogen storage disease type Ia - an in vitro study.
Orphanet J Rare Dis. 2024 Jul 30;19(1):283. doi: 10.1186/s13023-024-03201-1.
7
Cornstarch therapy in a patient with type III glycogen storage disease.
J Pediatr Gastroenterol Nutr. 1987 Jul-Aug;6(4):631-4. doi: 10.1097/00005176-198707000-00024.
8
Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease.
Eur J Pediatr. 2002 Oct;161 Suppl 1:S35-9. doi: 10.1007/s00431-002-1000-2. Epub 2002 Jul 31.
9
Sleep and quality of life of patients with glycogen storage disease on standard and modified uncooked cornstarch.
Mol Genet Metab. 2018 Mar;123(3):326-330. doi: 10.1016/j.ymgme.2017.09.003. Epub 2017 Sep 11.
10
Cornstarch requirements of the adult glycogen storage disease Ia population: A retrospective review.
J Inherit Metab Dis. 2020 Mar;43(2):269-278. doi: 10.1002/jimd.12160. Epub 2019 Sep 4.
本文引用的文献
1
Short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.
Orphanet J Rare Dis. 2024 Jul 9;19(1):258. doi: 10.1186/s13023-024-03274-y.
Zotero 插件